AtriCure ATRC 深 沪
已收盘 08-28 16:00:00 美东时间
48.54
-0.730
-1.48%
华盛通- 最 高49.98
- 今 开49.32
- 成交量 39.06万股
- 最 低 48.35
- 昨 收 49.27
- 总市值 24.69亿
- 52周最高 49.98
- 市盈率 静 --
- 换手率 0.77%
- 52周最低 25.36
- 委 比 57.98%
- 总股本 5086.63万
- 历史最高 89.18
- 量 比 0.57
- 振 幅 3.31%
- 历史最低 5.90
- 每 手 1
- 风险率 5.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
美股大行评级 | 首予买入！Jersey Mike's获13家大行评级；大摩、富国银行齐上调迈威尔科技目标价，最高升至310美元
今日重点评级关注：Truist Securities：维持CoreWeave"买入"评级，目标价从155美元升至165美元；百德：维持亚德诺"跑赢大市"评级，目标价从450美元升至675美元
08-25 11:47
Analog Devices To Rally Around 81%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Baird cut the price target for Chipotle Mexican Grill Inc (NYSE:CMG) from $44 to $40. Baird analyst Chris O’Cu...
08-24 21:30
BTIG Maintains Buy on AtriCure, Raises Price Target to $55
BTIG analyst Marie Thibault maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $45 to $55.
08-24 18:32
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
UBS Maintains Buy on AtriCure, Lowers Price Target to $50
UBS analyst Priya Sachdeva maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $55 to $50.
07-29 03:34
AtriCure Raises FY2026 GAAP EPS Guidance from $0.00-$0.04 to $0.05-$0.13 vs $0.05 Est
AtriCure (NASDAQ:ATRC) raises FY2026 GAAP EPS guidance from $0.00-$0.04 to $0.05-$0.13 vs $0.05 analyst estimate..
07-24 04:02
AtriCure Q2 Adj. EPS $0.18 Beats $0.00 Estimate, Sales $153.600M Beat $151.842M Estimate
AtriCure (NASDAQ:ATRC) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 1000 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $153.600 million whic...
07-24 04:02
AtriCure Raises FY2026 Adj EPS Guidance from $0.00-$0.04 to $0.24-$0.32 vs $0.06 Est; Raises FY2026 Sales Guidance from $600.000M-$610.000M to $602.000M-$610.000M vs $604.990M Est
AtriCure (NASDAQ:ATRC) raises FY2026 Adj EPS guidance from $0.00-$0.04 to $0.24-$0.32 vs $0.06 analyst estimate. Raises FY2026 sales outlook from $600.000 million-$610.000 million to $602.000 million-$610.000 million vs $604.990 million estimate.
07-24 04:02
Earnings Scheduled For July 23, 2026
Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is expected to report quarterly earnings at $0.78 per share on revenue of $123.06 million. • Infosys (NYSE...
07-23 19:11
